Suppr超能文献

开发微胶囊递释系统用于益生菌的长期保存作为生物治疗剂。

Development of microencapsulation delivery system for long-term preservation of probiotics as biotherapeutics agent.

机构信息

Department of Pharmaceutics, S.S.R. College of Pharmacy, Sayli-Silvassa Road, Sayli, Silvassa, Dora and Nagar Haveli 396230, India ; Hemchandracharya North Gujarat University, Patan, Gujarat 384265, India.

出版信息

Biomed Res Int. 2013;2013:620719. doi: 10.1155/2013/620719. Epub 2013 Aug 21.

Abstract

The administration of probiotic bacteria for health benefit has rapidly expanded in recent years, with a global market worth $32.6 billion predicted by 2014. The oral administration of most of the probiotics results in the lack of ability to survive in a high proportion of the harsh conditions of acidity and bile concentration commonly encountered in the gastrointestinal tract of humans. Providing probiotic living cells with a physical barrier against adverse environmental conditions is therefore an approach currently receiving considerable interest. Probiotic encapsulation technology has the potential to protect microorganisms and to deliver them into the gut. However, there are still many challenges to overcome with respect to the microencapsulation process and the conditions prevailing in the gut. This review focuses mainly on the methodological approach of probiotic encapsulation including biomaterials selection and choice of appropriate technology in detailed manner.

摘要

近年来,为了健康益处而使用益生菌的管理迅速扩大,预计到 2014 年,全球市场价值将达到 326 亿美元。大多数益生菌的口服给药结果导致缺乏在人类胃肠道中常见的高比例酸度和胆汁浓度的恶劣条件下生存的能力。因此,为益生菌活细胞提供对抗不利环境条件的物理屏障是目前受到广泛关注的一种方法。益生菌包埋技术有可能保护微生物并将其递送到肠道中。然而,在微囊化过程和肠道中占主导地位的条件方面,仍然存在许多挑战需要克服。这篇综述主要集中在益生菌包埋的方法学方法上,包括生物材料的选择和适当技术的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f11/3763591/fbeab38777d6/BMRI2013-620719.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验